Skip to main content
. 2012 Nov 20;4(3):274–280. doi: 10.1111/jdi.12019

Table 3. Incidence rates and hazard ratios for impaired insulin secretion and insulin resistance according to smoking status.

Never‐smokers Ex‐smokers Current smokers
n 353 583 263
Impaired insulin secretion
Cases (n)/person‐years 122/1,009 213/1,703 114/691
Incidence rate (per 1,000 person‐years) 120.9 125.1 165.0
HR (95% CI)
Model 1 1.0 1.00 (0.80–1.25) 1.38 (1.07–1.79)
Model 2 1.0 1.03 (0.82–1.29) 1.51 (1.16–1.97)
Model 3 1.0 1.06 (0.84–1.32) 1.55 (1.18–2.02)
Model 4 1.0 1.04 (0.83–1.30) 1.54 (1.16–2.03)
Model 5 1.0 1.02 (0.82–1.29) 1.89 (1.42–2.51)
Model 6 1.0 1.06 (0.84–1.33) 1.95 (1.44–2.63)
Model 7* 1.0 1.02 (0.81–1.29) 1.94 (1.42–2.65)
Insulin resistance
Cases (n)/person‐years 22/1,216 44/2,011 33/865
Incidence rate (per 1,000 person‐years) 18.1 21.9 38.2
HR (95% CI)
Model 1 1.0 1.19 (0.71–1.99) 2.15 (1.25–3.69)
Model 2 1.0 1.04 (0.62–1.75) 1.93 (1.10–3.38)
Model 3 1.0 0.92 (0.54–1.57) 1.59 (0.91–2.78)
Model 4 1.0 1.00 (0.59–1.69) 1.59 (0.88–2.85)
Model 5 1.0 1.03 (0.61–1.74) 1.42 (0.74–2.72)
Model 6 1.0 0.95 (0.56–1.61) 1.11 (0.67–1.79)
Model 7 1.0 0.94 (0.43–2.06) 1.06 (0.58–1.72)

Model 1: Adjusted for age. Model 2: Adjusted for age, familial history of diabetes (yes or no), alcohol consumption (0, 1–139 or ≥140 g/week), exercise (0, 1–119 or ≥120 min/week), systolic blood pressure, log‐transformed triglyceride and log‐transformed γ‐glutamyltransferase. Model 3: Adjusted for all factors in model 2 plus waist circumference. Model 4: Adjusted for all factors in model 2 plus leukocyte count. Model 5: Adjusted for all factors in model 2 plus changes in smoking status between the baseline and final examinations (no change, started smoking or quit smoking) and Δ waist circumference (Δ = final examination–baseline examination). Model 6: Adjusted for all factors in model 2 plus waist circumference, leukocyte count, changes in smoking status and Δ waist circumference.

Model 7: *Adjusted for all factors in model 6 among 1,100 men excluding 99 men who developed insulin resistance. †Adjusted for all factors in model 6 among 750 men excluding 449 men who developed impaired insulin secretion.

CI, confidence interval; HR, hazard ratio.